QQ客服 官方微博 反馈留言

浏览/检索结果: 共7条，第1-7条 帮助 限定条件 发表日期：2018     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 A randomized phase II trial of pyrotinib plus capecitabine versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer previously treated with taxanes, anthracyclines and/or trastuzumab 期刊论文 CANCER RESEARCH, 2018, 卷号: 78, 期号: 4 作者:  Xu, Binghe;  Ma, Fei;  Ouyang, Quchang;  Li, Wei;  Jiang, Zefei 收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05 Nuclear forkhead box O3a accumulation contributing to the proliferative suppression in liver cancer cells by PI3K/Akt signaling pathway 期刊论文 JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2018, 卷号: 14 作者:  Hou, Yibin;  Sun, Ge;  Jiang, Xu;  Zhu, Zhongsheng;  Yang, Jijin 收藏  |  浏览/下载：6/0  |  提交时间：2019/12/05 Akt  forkhead box O3a  liver cancer  PI3K inhibitor   Toll-like receptor 9 inactivation ameliorates ox-LDL injured HUVEC activity in vitro 期刊论文 INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 卷号: 11, 期号: 9 作者:  Zhu, Zhongsheng;  Li, Jinyu;  Kan, Lihong 收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05 TLR9  IRS869  ODN1826  HUVECs  ox-LDL   A randomized phase II trial of pyrotinib plus capecitabine versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer previously treated with taxanes, anthracyclines and/or trastuzumab 会议论文 作者:  Xu, Binghe;  Ma, Fei;  Ouyang, Quchang;  Li, Wei;  Jiang, Zefei 收藏  |  浏览/下载：10/0  |  提交时间：2019/12/05 Analysis of cognitive dysfunction-related influencing factors after elderly patients with vertebroarterial-type cervical spondylosis underwent low-temperature plasma ablation of nucleus pulposus 期刊论文 INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 卷号: 11, 期号: 4 作者:  Jiang, Minbo;  Zhang, Dong;  Zhu, Zhongsheng;  Xiao, Haijun;  Xue, Feng 收藏  |  浏览/下载：14/0  |  提交时间：2019/12/06 Elderly cervical spondylosis  low-temperature plasma ablation of nucleus pulposus  cognitive dysfunction  factor analysis   A randomized phase II trial of pyrotinib plus capecitabine versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer previously treated with taxanes, anthracyclines and/or trastuzumab 会议论文 CANCER RESEARCH, 2018-02-01 作者:  Xu, Binghe;  Ma, Fei;  Ouyang, Quchang;  Li, Wei;  Jiang, Zefei 收藏  |  浏览/下载：15/0  |  提交时间：2020/01/03 A randomized phase II trial of pyrotinib plus capecitabine versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer previously treated with taxanes, anthracyclines and/or trastuzumab 期刊论文 2018, 卷号: 78, 期号: 4 作者:  Xu, Binghe;  Ma, Fei;  Ouyang, Quchang;  Li, Wei;  Jiang, Zefei 收藏  |  浏览/下载：9/0  |  提交时间：2020/01/03